Peanut Antigen Composition Profiling With LC-MS/MS Release Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack the sensitivity and accuracy to determine the release profiles and allergenic signatures of peanut allergens in therapeutic compositions, particularly at low concentrations, which is crucial for quality control and predicting in vivo effects.
Innovation Solution
A highly sensitive method involving allergen digestion, fragmentation, and mass spectrometry analysis, such as LC-MS-MS, is used to detect and quantify peanut allergen digest products, allowing for the determination of allergen signatures and release profiles in compositions containing low levels of peanut allergens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to detect peanut allergens, then the detection process is simple, but the sensitivity and accuracy are insufficient for low concentration allergens
Solution Approach 1:
The allergen protein is segmented into peptide fragments through enzymatic digestion (e.g., trypsin) and subsequent fragmentation in mass spectrometry. This segmentation allows detection of smaller, more abundant peptide fragments rather than requiring detection of intact low-concentration allergen proteins, thereby achieving high sensitivity with conventional instrumentation.
Solution Approach 2:
Protein digest products serve as intermediaries between the intact allergen and the detection system. By digesting the allergen into peptides and using these digest products as proxies for allergen presence and concentration, the method enables sensitive detection without requiring direct measurement of the low-concentration intact allergen proteins.
2Reliability
If the method detects low level allergens accurately, then quality control and in vivo prediction improve, but the measurement process becomes more complex
Solution Approach 1:
The method replaces complex immunoassay-based detection systems with mass spectrometry-based peptide fingerprinting. Instead of relying on antibody binding that requires optimization for low concentrations, the system uses MS to detect and quantify specific peptide fragments, providing more reliable and reproducible results for quality control at low allergen levels.
Solution Approach 2:
The method changes the detection parameter from intact protein concentration to peptide fragment profile. By analyzing the fingerprint pattern of peptide fragments rather than directly measuring protein concentration, the system achieves more reliable detection and quantification of allergens at low concentrations, improving quality control accuracy.
3Loss of information
If the method provides detailed allergen signature information, then release profile prediction improves, but the analysis time increases
Solution Approach 1:
The method extracts and focuses on specific diagnostic peptide fragments that form the allergen fingerprint. Rather than analyzing every possible peptide or protein component, the system identifies and quantifies a limited set of characteristic peptide fragments that provide sufficient information for release profile prediction, thereby reducing analysis time while maintaining information quality.
Solution Approach 2:
The method uses partial digestion and selective peptide analysis, focusing only on the most informative peptide fragments for each allergen. This partial action approach provides sufficient allergen signature information for release profile prediction without requiring complete proteomic analysis, thus reducing the time needed for detailed characterization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides precise qualitative and quantitative information on batch-to-batch consistency and in vitro release profiles of peanut allergens, enabling effective quality control and prediction of in vivo behavior.
Implementation Method 1
detecting and identifying the allergen digest products by mass spectrometry
Implementation Method 2
digesting peanut allergens present in a composition to generate allergen digest products
Data Source
AI summary
Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.